Oncology & Cancer

Radiotherapy doubles survival for patients with mesothelioma

Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk, according to research presented at the ESTRO 38 conference.

Oncology & Cancer

Researchers study cost-effectiveness of rectal cancer treatments

Costs are on the rise for many kinds of medical treatments. UCLA researchers are looking for cost-effective ways to treat people who have locally advanced rectal cancer, a cancer located in the end section of the large intestine.

Oncology & Cancer

Stereotactic body RT promising for low-, intermediate-risk PCa

(HealthDay)—In men with low-risk and intermediate-risk prostate cancer, stereotactic body radiotherapy is associated with low rates of severe toxic events and high rates of biochemical control, according to a study published ...

page 2 from 23